Abbott's Sales Soared in Q1, but Not Enough to Satisfy Wall Street

Abbott's Sales Soared in Q1, but Not Enough to Satisfy Wall Street

Abbott Laboratories (NYSE: ABT) entered 2020 as a strong and growing business. For the quarter, Abbott Labs reported revenue of $10.5 billion, a 35% year-over-year jump. In the prior-year period, Abbott posted GAAP earnings of $564 million, or $0.31 per share.